Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simvastatin-fluconazole causing rhabdomyolysis.

Aasma Shaukat1, Mustafa Benekli, Georgirene D Vladutiu

  • 1School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA. medasha@acsu.buffalo.edu

The Annals of Pharmacotherapy
|July 5, 2003
PubMed
Summary

Concomitant use of simvastatin and fluconazole can lead to rhabdomyolysis, a serious muscle condition. Healthcare providers should monitor patients on statins and azole antifungals for potential drug interactions and toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case-Control Study.

Cancers·2026
Same author

Younger age at colorectal cancer diagnosis in hereditary gastrointestinal cancer predisposition syndromes and Lynch syndrome: a nationwide analysis.

Journal of gastrointestinal oncology·2026
Same author

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same author

Normalizing Catastrophe: Learning From Responses to Cancer Diagnosis.

JCO oncology practice·2026
Same author

Association of proximal adenomas with high-grade dysplasia with increased cumulative incidence of postpolypectomy colon cancer: A Surveillance, Epidemiology, and End Results-Medicare analysis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
Same author

Incremental Value of Adherence to Repeat Stool Test in Reducing Long-term Incidence of Colorectal Cancer.

Journal of clinical gastroenterology·2026

Area of Science:

  • Pharmacology
  • Clinical Toxicology
  • Drug Interactions

Background:

  • Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely prescribed for hyperlipidemia.
  • Azole antifungals, such as fluconazole, are commonly used to treat fungal infections.
  • Drug interactions involving statins can increase the risk of adverse events.

Observation:

  • An 83-year-old male experienced severe muscle weakness and elevated creatine kinase levels after initiating fluconazole while on simvastatin.
  • Symptoms resolved upon discontinuation of both simvastatin and fluconazole.
  • The patient had a history of congestive heart failure and hyperlipidemia.

Findings:

  • The concomitant use of simvastatin and fluconazole likely caused rhabdomyolysis in this patient.

Related Experiment Videos

  • Azole antifungals can inhibit cytochrome P450 enzymes, leading to increased statin levels and toxicity.
  • This case represents a probable drug interaction between simvastatin and fluconazole, resulting in rhabdomyolysis.

    • Implications:

    • Clinicians must be vigilant for drug interactions between statins and azole antifungals.
    • Patients, especially those with comorbidities or on multiple medications, require close monitoring for statin-induced toxicity.
    • This case highlights the importance of reviewing medication regimens to prevent adverse drug events, particularly in vulnerable populations.